|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash and due from financial institutions | ||||||
| Due from Federal Reserve Bank and interest-bearing deposits in banks | ||||||
| Securities available-for-sale, at fair value (amortized cost $174,278 and $369,155, net of allowance for credit losses of $0 and $0) | ||||||
| Due from Federal Reserve Bank and interest-bearing deposits in other financial institutions | ||||||
| Total cash and cash equivalents | ||||||
| Debt securities available-for-sale, at fair value (amortized cost $292,809 and $218,488, net of allowance for credit losses of $0 and $0) | ||||||
| Loans, net of allowance for credit losses on loans of $22,789 and $22,261 | ||||||
| Federal Home Loan Bank stock, at cost | ||||||
| Premises and equipment, net | ||||||
| Cash surrender value of bank-owned life insurance policies | ||||||
| Accrued interest receivable and other assets | ||||||
| Total assets | ||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||
| Non-interest-bearing deposits | ||||||
| Interest-bearing | ||||||
| Total deposits | ||||||
| Short-term borrowings | ||||||
| Subordinated debentures, net | ||||||
| Accrued interest payable and other liabilities | ||||||
| Total liabilities | ||||||
| Shareholders' equity | ||||||
| Preferred stock - no par value; 5,000,000 shares authorized; no shares issued and outstanding at September 30, 2026 and December 31, 2025 | ||||||
| Common stock - no par value; 25,000,000 shares authorized; 10,996,074 and 10,947,967 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||
| Retained earnings | ||||||
| Accumulated other comprehensive loss, net of taxes | ||||||
| Total shareholders' equity | ||||||
| Total liabilities and shareholders' equity |
Loading...